Department of Immunology, Mayo Clinic, Rochester, Minnesota, United States of America ; Department of Dermatology, Mayo Clinic, Rochester, Minnesota, United States of America ; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, United States of America.
PLoS One. 2013 Nov 13;8(11):e78687. doi: 10.1371/journal.pone.0078687. eCollection 2013.
Human and animal studies strongly suggest that dietary gluten could play a causal role in the etiopathogenesis of type 1 diabetes (T1D). However, the mechanisms have not been elucidated. Recent reports indicate that the intestinal microbiome has a major influence on the incidence of T1D. Since diet is known to shape the composition of the intestinal microbiome, we investigated using non-obese diabetic (NOD) mice whether changes in the intestinal microbiome could be attributed to the pro- and anti-diabetogenic effects of gluten-containing and gluten-free diets, respectively. NOD mice were raised on gluten-containing chows (GCC) or gluten-free chows (GFC). The incidence of diabetes was determined by monitoring blood glucose levels biweekly using a glucometer. Intestinal microbiome composition was analyzed by sequencing 16S rRNA amplicons derived from fecal samples. First of all, GCC-fed NOD mice had the expected high incidence of hyperglycemia whereas NOD mice fed with a GFC had significantly reduced incidence of hyperglycemia. Secondly, when the fecal microbiomes were compared, Bifidobacterium, Tannerella, and Barnesiella species were increased (p = 0.03, 0.02, and 0.02, respectively) in the microbiome of GCC mice, where as Akkermansia species was increased (p = 0.02) in the intestinal microbiomes of NOD mice fed GFC. Thirdly, both of the gluten-free chows that were evaluated, either egg white based (EW-GFC) or casein based (C-GFC), significantly reduced the incidence of hyperglycemia. Interestingly, the gut microbiome from EW-GFC mice was similar to C-GFC mice. Finally, adding back gluten to the gluten-free diet reversed its anti-diabetogenic effect, reduced Akkermansia species and increased Bifidobacterium, Tannerella, and Barnesiella suggesting that the presence of gluten is directly responsible for the pro-diabetogenic effects of diets and it determines the gut microflora. Our novel study thus suggests that dietary gluten could modulate the incidence of T1D by changing the gut microbiome.
人类和动物研究强烈表明,膳食中的麸质可能在 1 型糖尿病(T1D)的发病机制中起因果作用。然而,其机制尚未阐明。最近的报告表明,肠道微生物组对 T1D 的发病率有重大影响。由于饮食已知会影响肠道微生物组的组成,因此我们使用非肥胖型糖尿病(NOD)小鼠研究了肠道微生物组的变化是否可以归因于含麸质和无麸质饮食的促糖尿病和抗糖尿病作用。NOD 小鼠分别用含麸质的饲料(GCC)和无麸质的饲料(GFC)喂养。通过使用血糖仪每周两次监测血糖水平来确定糖尿病的发病率。通过对来自粪便样本的 16S rRNA 扩增子进行测序来分析肠道微生物组的组成。首先,用 GCC 喂养的 NOD 小鼠出现了预期的高血糖发生率,而用 GFC 喂养的 NOD 小鼠的高血糖发生率则显著降低。其次,当比较粪便微生物组时,在 GCC 小鼠的微生物组中双歧杆菌、 Tannerella 和 Barnesiella 物种增加(p = 0.03、0.02 和 0.02),而在 GFC 喂养的 NOD 小鼠的肠道微生物组中 Akkermansia 物种增加(p = 0.02)。第三,评估的两种无麸质饲料,即蛋清基(EW-GFC)或酪蛋白基(C-GFC),均显著降低了高血糖的发生率。有趣的是,EW-GFC 小鼠的肠道微生物组与 C-GFC 小鼠相似。最后,将麸质添加回无麸质饮食中,逆转了其抗糖尿病作用,降低了 Akkermansia 物种,增加了双歧杆菌、 Tannerella 和 Barnesiella,这表明麸质的存在直接导致了饮食的促糖尿病作用,并决定了肠道微生物群。我们的新研究表明,膳食中的麸质可能通过改变肠道微生物组来调节 T1D 的发病率。